1 / 7

Veterinary Pain Management Market Size, Share, Growth and Forecast to 2026

Veterinary Pain Management Market Size, Share & Trends Analysis Report By Product (NSAIDs, Anesthetics), By Indication, By Animal Type (Companion, Livestock), By End Use, And Segment Forecasts, 2019 - 2026

Marsh
Download Presentation

Veterinary Pain Management Market Size, Share, Growth and Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Veterinary Pain Management Market Analysis, Size, Growth, Share & Forecast to 2026 | Grand View Research Inc. “Veterinary Pain Management Market Worth $1.73 Billion By 2026” The global Veterinary Pain Management market size is expected to reach USD 1.73 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.3% during the forecast period. Growing companion adoption and incidence of veterinary diseases is expected to boost the growth. Moreover, increasing income in the developing countries is another growth driver. For instance, according to the American Veterinary Medical Association (AVMA) in 2017, around 46% household had multiple types of pets in U.S. North America held the dominant share of the veterinary pain management market in 2018, due to the favorable pet insurance policies and strategic initiatives adopted by various companies operating in the region. For instance, in August 2018, Zoetis Inc. acquired Abaxis in a probe to expand its veterinary products portfolio. Increasing number of veterinary practitioners are anticipated to create growth opportunities in the market. High prevalence of chronic diseases such as cancer, diabetes, and osteoarthritis among others. These factors are projected to propel the market in the forthcoming years. Furthermore, key players are implementing newer strategies such as product launch, merger and acquisitions, regional expansions etc. for increasing their foothold in the market. For instance, in March 2016, Dechra Pharmaceuticals acquired Putney in order to improve its animal product portfolio. In October 2018, Boehringer Ingelheim invested USD 80 million for R&D pertinent to veterinary vaccines in France. Moreover, increasing pet insurance coverage are further fueling the market growth. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/veterinary-pain-management-market Follow Us:

  2. Further key findings from the report suggest: NSAIDs accounted for the largest market share in terms of revenue in 2018, owing to the increasing incidence of chronic diseases • Companion animal segment is expected to exhibit lucrative growth over the forecast period owing to rise in pet adoption and expenditure for better pet care • Osteoarthritis (OA) segment is expected to hold the largest market share in terms of revenue due to increasing incidence of obesity which propels the risk for OA • Post-operative pain segment is expected to exhibit lucrative growth over the forecast period due to the increasing number of surgeries for chronic disorders • Asia Pacific is anticipated to witness lucrative growth due to rise in pet adoption and expendable income, especially in Japan and India • Some of the key companies operating in the veterinary pain management market are Zoetis, CEVA, Boehringer Ingelheim GmbH, Bayer, Merck, and Elanco. • Grand View Research has segmented the global veterinary pain management market on the basis of product, indication, animal type, end use, and region: Veterinary Pain Management Product Outlook (Revenue, USD Million, 2014 - 2026) NSAIDs • Anesthetics • Opioids • Others • Veterinary Pain Management Indication Outlook (Revenue, USD Million, 2014 - 2026) Osteoarthritis • Post-operative pain • Others • Veterinary Pain Management Animal Type Outlook (Revenue, USD Million, 2014 – 2026 Livestock animal • Companion Animal • Veterinary Pain Management End Use Outlook (Revenue, USD Million, 2014 - 2026) Hospitals & Clinics • Follow Us:

  3. Others • Veterinary Pain Management Regional Outlook (Revenue, USD Million, 2014 - 2026) North America • oU.S. oCanada Europe • oU.K. oGermany oFrance oItaly oSpain Asia Pacific • oJapan oChina oIndia Latin America • oBrazil oMexico Middle East & Africa • oSouth Africa Table of Content Chapter 1 Report Scope 1.1 Segment Market Scope 1.2 Regional Scope 1.3 Estimates & Forecast Timeline Chapter 2 Research Methodology 2.1 Model Details 2.1.1 Regression and variable analysis Follow Us:

  4. 2.1.2 Total addressable market (TAM) 2.2 Information Procurement 2.3 List Of Primary Sources 2.3.1 Purchased database: 2.3.2 GVR’s internal database 2.4 Primary Interview Breakup 2.4.1 Data for primary interviews, by sources 2.4.2 Data for primary interviews, by region 2.5 List Of Secondary Sources Chapter 3 Report Objectives 3.1 Objectives Chapter 4 Executive Summary 4.1 Market Summary Chapter 5 Veterinary pain management Market: Industry Outlook 5.1 Market Variable Analysis 5.2 Market Driver Analysis 5.2.1 Rising Number Of Pet Owners & Veterinary Practioners 5.2.2 Increasing Incidence Of Pet Obesity 5.2.3 Rising Number Of Government Initiatives 5.3 Market Restraints Analysis 5.3.1 High Pet Care Costs 5.4 Business Environment Analysis Tools 5.4.1 Veterinary pain management Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological) 5.4.2 Porter’s Five Forces Analysis Chapter 6 Regulatory & Political Forces 6.1 Regulatory Landscape 6.1.1 List of regulations, by country 6.2 Political Landscape, Current & Future Scenario 6.2.1 North America 6.2.2 Europe 6.2.3 Asia Pacific 6.2.4 Latin America 6.2.5 MEA Follow Us:

  5. Chapter 7 Competitive & Vendor Landscape 7.1 Market Participation Categorization 7.1.1 Market leader 7.1.2 Innovators 7.2 Strategic Initiatives & Outcome Analysis Chapter 8 Veterinary pain management Market: Product Analysis 8.1 Product Business Analysis 8.2 NSAIDs 8.2.1 NSAIDs estimates and forecasts, 2014 - 2026 (USD Million) 8.2.2 Anesthetics 8.2.2.1 Anesthetics estimates and forecasts, 2014 - 2026 (USD Million) 8.2.3 Opioids 8.2.3.1 Opioids estimates and forecasts, 2014 - 2026 (USD Million) 8.2.4 Others 8.2.4.1 Others estimates and forecasts, 2014 - 2026 (USD Million) Chapter 9 Veterinary pain management Market: Indication Analysis 9.1 Site Business Analysis 9.2 Osteoarthritis 9.2.1 Osteoarthritis Animal estimates and forecasts, 2014 - 2026 (USD Million) 9.3 Post-operative pain 9.3.1 Post operative pain market estimates and forecasts, 2014 - 2026 (USD Million) 9.4 Others 9.4.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 10 Veterinary pain management Market: Animal Analysis 10.1 Animal Business Analysis 10.2 Livestock 10.2.1 Livestock estimates and forecasts, 2014 - 2026 (USD Million) 10.3 Companion 10.3.1 Companion market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 11 Veterinary Pain Management Market: End Use Analysis 11.1 End use Business Analysis 11.2 Hospitals & Clinics 11.2.1 Hospitals & Clinics estimates and forecasts, 2014 - 2026 (USD Million) 11.3 Others Follow Us:

  6. 11.3.1 others market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 12 Veterinary pain management Market: Regional Analysis 12.1 North America 12.1.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.1.2 U.S. 12.1.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.1.3 Canada 12.1.3.1 Management Market estimates and forecasts, 2014 - 2026 (USD Million) 12.2 Europe 12.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.2.2 Germany 12.2.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.2.3 U.K. 12.2.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.3 Asia Pacific 12.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.3.2 China 12.3.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.3.3 India 12.3.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.4 Latin America 12.4.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.4.2 Mexico 12.4.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.4.3 Brazil 12.4.3.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.5 MEA 12.5.1 Market estimates and forecasts, 2014 - 2026 (USD Million) 12.5.2 South Africa 12.5.2.1 Market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 13 Company Profiles 13.1 Key Company Profiles Chapter 14 Recommendations/Conclusion Follow Us:

  7. 14.1 Recommendations 14.2 Conclusion About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related